Covid vaccine for children in six months, says SII CEO Adar Poonawalla
The 27th edition of the CII Partnership Summit is being held on a virtual platform under the theme of ‘Partnerships for Building a New World’.
New Delhi: Serum Institute of India's (SII), manufacturer of Covishield, to come up with a vaccine, Novavax, for children aged three years and above in the next six months.
SII CEO Adar Poonawalla at CII Partnership Summit held virtually, said "Vaccine for children aged three years and above will be launched in the next six months."
The Novavaxshot, which the world's largest producer of vaccines calls Covovax, has shown good results in trials in children aged three and older, Adar Poonawalla told a virtual conference organised by the Confederation of Indian Industry, according to Reuters.
"On the back of enough data, it is safe to say that booster vaccine doses are a proven strategy to get antibodies up to a great extent", said Poonawalla on Omicron, a new coronavirus variant.
The 27th edition of the CII Partnership Summit is being held on a virtual platform under the theme of ‘Partnerships for Building a New World’.
The 27th edition of The CII Partnership Summit is being held virtually, in partnership with the Department for Promotion of Industry and Internal Trade, Ministry of Commerce and Industry, Government of India from 13 -15 December 2021.
